Intravascular thrombosis and leukocyte destruction in vivo by heterologous antilymphocyte serum.
D000818:Animals; D000941:Antigens; D000961:Antilymphocyte Serum / Q000009:adverse effects*; D001792:Blood Platelets / Q000276:immunology; D004912:Erythrocytes / Q000276:immunology; D006386:Hemagglutination Tests; D005779:Immunodiffusion; D008214:Lymphocytes / Q000276:immunology*; D010784:Photomicrography; D011817:Rabbits; D013921:Thrombocytopenia / Q000209:etiology*; D013924:Thrombophlebitis / Q000150:complications / Q000209:etiology* / Q000276:immunology; D013950:Thymus Gland / Q000276:immunology; D014680:Veins / Q000473:pathology
D000941:Antigens; D000961:Antilymphocyte Serum